BCL2 and acute myeloid leukemia: Elevated BCL-2 levels promote cancer cell survival and growth, correlating with disease progression, metastasis, and adverse clinical outcomes across several malignancies [83–86], including acute myeloid leukemia (AML) and B-cell non-Hodgkin lymphoma (B-NHL).